169 related articles for article (PubMed ID: 28580721)
1. Persistent hemolytic disease of the fetus and newborn (HDFN) associated with passive acquisition of anti-D in maternal breast milk.
Li M; Blaustein JC
Transfusion; 2017 Sep; 57(9):2121-2124. PubMed ID: 28580721
[TBL] [Abstract][Full Text] [Related]
2. Hemolytic disease of the fetus and newborn with late-onset anemia due to anti-M: a case report and review of the Japanese literature.
Yasuda H; Ohto H; Nollet KE; Kawabata K; Saito S; Yagi Y; Negishi Y; Ishida A
Transfus Med Rev; 2014 Jan; 28(1):1-6. PubMed ID: 24262303
[TBL] [Abstract][Full Text] [Related]
3. Identification of red blood cell antibodies in maternal breast milk implicated in prolonged hemolytic disease of the fetus and newborn.
Leonard A; Hittson Boal L; Pary P; Mo YD; Jacquot C; Luban NL; Darbari DS; Webb J
Transfusion; 2019 Apr; 59(4):1183-1189. PubMed ID: 30720868
[TBL] [Abstract][Full Text] [Related]
4. Passive transfer of alloantibodies through breast milk as a mediator of hemolytic anemia.
Abels E; Jacobs JW; Prior D; Willets LC; Sostin N; Tormey CA; Binns TC
Transfusion; 2023 Nov; 63(11):2188-2196. PubMed ID: 37706556
[TBL] [Abstract][Full Text] [Related]
5. Severe anti-D haemolytic disease of fetal and newborn in rhesus D negative primigravida.
Hassan MZ; Iberahim S; Abdul Rahman WSW; Zulkafli Z; Bahar R; Ramli M; Mohd Noor NH; Mustaffa R
Malays J Pathol; 2019 Apr; 41(1):55-58. PubMed ID: 31025639
[TBL] [Abstract][Full Text] [Related]
6. Effect of screening for red cell antibodies, other than anti-D, to detect hemolytic disease of the fetus and newborn: a population study in the Netherlands.
Koelewijn JM; Vrijkotte TG; van der Schoot CE; Bonsel GJ; de Haas M
Transfusion; 2008 May; 48(5):941-52. PubMed ID: 18248570
[TBL] [Abstract][Full Text] [Related]
7. Do red cell alloantibodies continue to challenge breast fed babies?
Rasalam JE; Kumar S; Amalraj P; Bal HS; Mathai J; Kumar M; Sridhar S; Daniel D
Transfus Med; 2020 Aug; 30(4):281-286. PubMed ID: 32083382
[TBL] [Abstract][Full Text] [Related]
8. Severe hemolytic disease of the fetus and newborn due to allo-anti-D in a patient with a partial DEL phenotype arising from the variant allele described as RHD*148+1T (RHD*01EL.31).
Turley E; McGowan EC; Hyland CA; Schoeman EM; Flower RL; Skoll A; Delisle MF; Nelson T; Clarke G; Au N
Transfusion; 2018 Oct; 58(10):2260-2264. PubMed ID: 30222865
[TBL] [Abstract][Full Text] [Related]
9. Anti-C causing severe hemolytic disease of the fetus and newborn: a rare case report.
Sahoo D; Anuragaa S; Abhishekh B
Immunohematology; 2023 Apr; 39(1):11-14. PubMed ID: 37017597
[TBL] [Abstract][Full Text] [Related]
10. Update on HDFN: new information on long-standing controversies.
Eder AF
Immunohematology; 2006; 22(4):188-95. PubMed ID: 17430078
[TBL] [Abstract][Full Text] [Related]
11. Hemolytic disease and reticulocytopenia of the newborn attributable to maternal immunoglobulin G anti-M reacting optimally at cold temperatures.
Andersen LH; Jacob EK; McThenia SS; Tauscher CD; Patterson ER; Oliveira JL; Rodriguez V
Transfusion; 2021 Mar; 61(3):974-978. PubMed ID: 33444461
[TBL] [Abstract][Full Text] [Related]
12. Hemolytic disease of the fetus and newborn caused by an antibody to a low-prevalence antigen, anti-SARA.
Towns D; Hannon J; Hendry J; Barnes J; Goldman M
Transfusion; 2011 Sep; 51(9):1977-9. PubMed ID: 21414007
[TBL] [Abstract][Full Text] [Related]
13. Absence of hemolytic disease of fetus and newborn despite maternal high-titer IgG anti-Ku.
Kakaiya RM; Whaley A; Howard-Menk C; Rami J; Papari M; Campbell-Lee S; Malecki Z
Immunohematology; 2010; 26(3):119-23. PubMed ID: 21214298
[TBL] [Abstract][Full Text] [Related]
14. More data needed to establish maternal breast milk IgG as cause for anti-D hemolytic disease of fetus and newborn.
Strauss RG; Storry JR
Transfusion; 2018 Mar; 58(3):828-829. PubMed ID: 29528155
[No Abstract] [Full Text] [Related]
15. Anti-M induced severe haemolytic disease of foetus and newborn in a Malay woman with recurrent pregnancy loss.
Mohd Nazri H; Noor Haslina MN; Shafini MY; Noor Shaidatul Akmal AR; Rapiaah M; Wan Zaidah A
Malays J Pathol; 2017 Apr; 39(1):73-76. PubMed ID: 28413208
[TBL] [Abstract][Full Text] [Related]
16. Recurrent fetal hydrops with maternal M alloimmunisation: not a benign condition.
Yu M; Graham K; Pasalic L; Alahakoon TI
BMJ Case Rep; 2019 Jul; 12(7):. PubMed ID: 31331930
[TBL] [Abstract][Full Text] [Related]
17. [The importance of antenatal immunoprophylaxis for prevention of hemolytic disease of the fetus and newborn].
Starcević M; Mataija M; Sović D; Dodig J; Matijević R; Kukuruzović M
Acta Med Croatica; 2011 Mar; 65(1):49-54. PubMed ID: 21568074
[TBL] [Abstract][Full Text] [Related]
18. Hydrops fetalis with isolated massive ascites in a preterm neonate with rhesus disease.
Nourkami-Tutdibi N; Geipel M; Meyberg-Solomayer G; Takacs Z; Meyer S
Wien Med Wochenschr; 2022 Oct; 172(13-14):290-291. PubMed ID: 33738630
[TBL] [Abstract][Full Text] [Related]
19. Fatal hemolytic disease of the fetus and newborn associated with anti-Jr.
Peyrard T; Pham BN; Arnaud L; Fleutiaux S; Brossard Y; Guerin B; Desmoulins I; Rouger P; Le Pennec PY
Transfusion; 2008 Sep; 48(9):1906-11. PubMed ID: 18522708
[TBL] [Abstract][Full Text] [Related]
20. In vitro assessment of recombinant, mutant immunoglobulin G anti-D devoid of hemolytic activity for treatment of ongoing hemolytic disease of the fetus and newborn.
Nielsen LK; Green TH; Sandlie I; Michaelsen TE; Dziegiel MH
Transfusion; 2008 Jan; 48(1):12-9. PubMed ID: 17764508
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
